Recovery of complete genomes of canine parvovirus from clinical samples.
CPV-2
Canine parvovirus
MinION nanopore
multiplex PCR
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
13 Jul 2023
13 Jul 2023
Historique:
pubmed:
28
7
2023
medline:
28
7
2023
entrez:
28
7
2023
Statut:
epublish
Résumé
Canine parvovirus (CPV) is a highly pathogenic virus that affects dogs, especially puppies. CPV is believed to have evolved from feline panleukopenia virus (FPV), eventually giving rise to three antigenic types, CPV-2a, 2b, and 2c. CPV-2 is recognized for its resilience in contaminated environments, ease of transmission among dogs, and pathogenicity for puppies. Despite the relevance of the virus, complete genome sequences of CPV available at GenBank, to date, are scarce. In the current study, we have developed a methodology to allow the recovery of complete CPV-2 genomes directly from clinical samples. For this, seven fecal samples from Gurupi, Tocantins, North Brazil, were collected from puppies with clinical signals of viral enteritis, and submitted to viral DNA isolation and amplification. Two multiplex PCR strategies were designed including primers targeting fragments of 400 base pairs (bp) and 1,000 bp along the complete genome. Sequencing was performed with the Nanopore
Identifiants
pubmed: 37502963
doi: 10.1101/2023.07.12.548703
pmc: PMC10369981
pii:
doi:
Types de publication
Preprint
Langues
eng
Déclaration de conflit d'intérêts
Conflicts of Interest The authors declare no conflict of interest.